Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ageless vs Henry Meds

Ageless
Graded #24

Higher grade

vs+7
Henry Meds
Graded #34

Lower grade

The verdict

Ageless takes it — 83/100 to 76/100.

Ageless grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the broadest compounded storefronts on the board — GLP-1, NAD+, sermorelin, TRT and more under one roof, in both injectable and oral routes, on low headline pricing (semaglutide $119/mo, tirzepatide $169/mo) — offset by a compounded-only catalog and an undisclosed state list.

Assume any provider we list may compensate us — we may earn a commission at no cost to you. It never changes the WeighScore.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAgeless +18
90
72
Dose & formulationAgeless +10
90
80
Clinical oversightEven
80
80
Labs & monitoringEven
78
78
FulfillmentAgeless +6
84
78
Contract termsAgeless +4
82
78
Ageless · left barHenry Meds · right bar

The numbers

MetricAgelessHenry Meds
WeighScore83/10076/100
GradeBC
Scorecard rank#24#34
Semaglutide$119/mo$249/mo
Tirzepatide$169/mo$349/mo
CoverageVaries by stateMulti-state
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Ageless

Graded #24 · B

Strengths

  • Unusually broad compounded menu — GLP-1, NAD+, sermorelin, TRT, LDN and more, in both injectable and oral formats
  • Low headline GLP-1 pricing — semaglutide $119/mo, tirzepatide $169/mo — no insurance, with Klarna/Affirm financing
  • Fully online: licensed-clinician review and discreet delivery, with upfront compounded/not-FDA disclosures
  • Oral routes available (drops and troches), not injection-only

Where it loses points

  • Everything is compounded and not FDA-approved — not equivalent to brand Wegovy/Ozempic/Zepbound
  • Oral GLP-1 drops and troches lack robust absorption/efficacy evidence versus injectables
  • No published state-availability list and no named legal entity or medical group
  • Thin public track record, and advertised prices are floors set after clinical review
Henry Meds

Graded #34 · C

Strengths

  • Simple flat-fee model
  • Established brand
  • Both molecules

Where it loses points

  • Higher pricing than newer entrants
  • Compounded only

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 34 providers, CoreAge Rx grades highest at 94/100 (A). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard